anyplex
tm
ii
detect
kit
seegen
seoul
south
korea
multiplex
realtim
pcr
assay
base
tag
oligonucleotid
cleavag
extens
prospect
studi
evalu
assay
compar
seeplex
ace
detect
kit
seegen
multiplex
endpoint
pcr
kit
total
consecut
respiratori
specimen
test
assay
parallel
detect
posit
case
respect
posit
percent
agreement
neg
percent
agreement
kappa
valu
assay
confid
interv
ci
ci
ci
respect
monoplex
pcr
sequenc
sampl
discrep
result
reveal
major
result
concord
result
assay
conclus
assay
produc
result
compar
assay
respiratori
viral
infect
respons
substanti
morbid
pediatr
adult
popul
time
accur
diagnosi
infect
essenti
patient
care
set
divers
suscept
infant
children
older
adult
patient
compromis
immun
system
individu
underli
cardiopulmonari
diseas
glezen
et
al
weinberg
et
al
earli
diagnosi
respiratori
virus
play
import
role
clinic
manag
reduc
complic
antibiot
use
unnecessari
laboratori
test
jernigan
et
al
mahoni
et
al
renaud
et
al
seeplex
ace
detect
kit
seegen
seoul
south
korea
enabl
simultan
detect
respiratori
virus
reaction
per
sampl
use
dual
prime
oligonucleotid
pcr
primer
perform
demonstr
previou
studi
show
time
resourc
save
bibbi
et
al
drew
et
al
weinberg
et
al
yoo
et
al
recent
ii
detect
kit
seegen
tag
oligonucleotid
cleavag
extens
toce
technolog
develop
toce
technolog
novel
approach
realtim
pcr
use
compon
pitcher
catcher
accomplish
uniqu
signal
gener
target
bound
pitcher
toce
assay
move
detect
point
target
sequenc
catcher
design
uniqu
catcher
result
duplex
catcher
predict
melt
temperatur
profil
cho
et
al
chun
lee
achiev
approv
ce
health
canada
ministri
food
drug
safeti
korea
sold
countri
europ
canada
asia
simultan
detect
respiratori
virus
human
bocaviru
hbov
human
enteroviru
hev
influenza
viru
inf
type
b
parainfluenza
viru
piv
type
respiratori
syncyti
viru
rsv
type
b
adenoviru
adv
human
metapneumoviru
hmpv
coronaviru
cov
human
rhinoviru
hrv
profil
similar
profil
includ
hbov
hev
piv
cov
cov
aim
present
studi
compar
perform
addit
evalu
analyt
perform
studi
carri
routin
diagnost
laboratori
set
use
nonselect
clinic
specimen
korean
patient
prospect
studi
approv
institut
review
board
samsung
medic
center
three
hundr
sixtyf
nonselect
consecut
clinic
respiratori
specimen
patient
obtain
patient
includ
adult
pediatr
patient
whose
median
age
year
rang
day
year
nasopharyng
npa
bronchoalveolar
lavag
bal
fluid
sampl
submit
test
januari
februari
sampl
simultan
analyz
aliquot
specimen
immedi
store
nucleic
acid
extract
specimen
magna
pure
lc
total
nucleic
acid
isol
kit
roch
mannheim
germani
microlab
starlet
hamilton
reno
nv
usa
starmag
viru
kit
seegen
final
elut
volum
sampl
kit
bacteriophag
ad
intern
control
specimen
accord
manufactur
instruct
random
hexamerprim
complementari
dna
cdna
synthesi
product
gener
use
revertaid
first
strand
cdna
synthesi
kit
fermenta
ontario
canada
accord
manufactur
instruct
cdna
prepar
subject
pcr
procedur
accord
manufactur
instruct
seegen
briefli
parallel
reaction
set
contain
mastermix
contamin
control
reagent
cdna
one
pair
supplement
primer
mix
primer
mix
b
thermal
cycl
condit
follow
min
follow
cycl
follow
singl
incub
min
amplif
product
detect
use
capillari
electrophoresi
technolog
screen
tape
system
ltd
loanhead
uk
cdna
synthesi
perform
cdna
synthesi
premix
seegen
extract
rna
set
b
use
accord
manufactur
instruct
briefli
assay
conduct
final
volum
contain
cdna
rv
primer
master
mix
realtim
pcr
detect
system
biorad
hercul
ca
usa
follow
condit
min
min
follow
cycl
min
reaction
catcher
melt
temperatur
analysi
perform
cool
reaction
mixtur
maintain
mixtur
heat
mixtur
fluoresc
measur
continu
temperatur
increas
melt
peak
deriv
initi
fluoresc
f
versu
temperatur
curv
specimen
show
discrep
assay
verifi
use
monoplex
pcr
sequenc
blind
manner
primer
monoplex
pcr
singl
nest
pcr
format
ident
primer
assay
pcr
product
purifi
power
gel
extract
kit
takara
bio
inc
shiga
japan
purifi
templat
sequenc
bigdy
termin
cycl
sequenc
kit
life
technolog
foster
citi
ca
usa
analyz
abi
dna
analyz
life
technolog
sinc
detect
bocaviru
bov
hev
adv
f
hrv
c
exclud
result
comparison
assay
serial
dilut
plasmid
contain
target
gene
use
determin
analyt
sensit
vector
use
plasmid
dna
prepar
serial
dilut
prepar
plasmid
dna
made
copi
per
reaction
determin
analyt
sensit
assay
mpv
bov
sampl
isol
patient
sequenc
confirm
direct
sequenc
standard
strain
obtain
american
type
cultur
collect
atcc
ten
replic
dilut
step
perform
lower
detect
limit
defin
lowest
concentr
detect
replica
assay
crossreact
assay
assess
use
ten
differ
bacteria
streptococcu
pneumonia
streptococcu
pyogen
staphylococcu
epidermidi
moraxella
catarrhali
pseudomona
aeruginosa
escherichia
coli
klebsiella
pneumonia
staphylococcu
aureu
neisseria
meningitidi
haemophilu
influenza
obtain
atcc
manassa
va
usa
dna
suppli
sampl
extract
assay
assay
adher
procedur
use
sampl
process
statist
analys
perform
use
spss
softwar
version
spss
inc
chicago
il
usa
vassarstat
websit
http
vassarstatsnet
use
interrat
agreement
statist
kappa
calcul
compar
detect
respiratori
virus
assay
pvalu
less
consid
statist
signific
total
sampl
posit
respect
among
virus
test
use
method
posit
percent
agreement
assay
confid
interv
ci
neg
percent
agreement
ci
kappa
valu
method
ci
result
viru
present
tabl
sixtyf
sampl
identifi
posit
sampl
assay
identifi
neg
assay
sampl
discrep
virus
discrep
viru
detect
hand
clinic
sampl
neg
assay
identifi
posit
assay
analysi
sampl
yield
discrep
result
assay
assay
monoplex
realtim
revers
transcriptionpolymeras
chain
reaction
rtpcr
gene
sequenc
perform
discrep
result
result
monoplex
pcr
sequenc
reveal
concord
result
assay
hand
discrep
result
exhibit
posit
assay
none
concord
result
assay
overal
result
monoplex
pcr
sequenc
reveal
major
sampl
identifi
posit
assay
also
exhibit
posit
result
except
inf
tabl
detect
limit
detect
kit
respiratori
virus
approxim
copiesreact
evalu
crossreact
detect
specif
differ
bacteri
refer
strain
test
use
assay
procedur
use
clinic
sampl
rv
detect
assay
assay
result
neg
nonspecif
posit
reaction
observ
compar
perform
multiplex
pcr
kit
detect
respiratori
virus
use
clinic
respiratori
sampl
perform
monoplex
pcr
direct
sequenc
blind
manner
sampl
yield
discrep
result
assay
present
studi
sampl
posit
respect
volum
sampl
ad
assay
almost
time
volum
ad
assay
could
contribut
higher
number
posit
sampl
compar
assay
major
sampl
identifi
posit
assay
confirm
posit
monoplex
realtim
rtpcr
gene
sequenc
howev
discrep
result
inf
monoplex
pcr
sequenc
reveal
neg
suggest
fals
posit
inf
assay
nucleic
acid
contamin
crossreact
spuriou
primer
interact
howev
possibl
may
detect
inf
superior
sensit
compar
monoplex
pcr
sequenc
exclud
recent
studi
report
perform
show
increas
sensit
compar
seeplex
ace
detect
kit
seegen
although
determin
diagnost
accuraci
refer
method
cho
et
al
kim
et
al
system
limit
regard
intern
control
facil
artifici
target
includ
pcr
mastermix
allow
valid
pcr
step
without
control
rna
extract
revers
transcript
step
bibbi
et
al
addit
bacteriophag
extract
allow
rtpcr
system
monitor
rna
extract
revers
transcript
step
cho
et
al
dreier
et
al
nevertheless
intern
control
give
inform
specimen
qualiti
prevent
misjudg
sampl
error
sinc
exogen
control
advantag
workload
compar
given
assay
requir
agaros
gel
detect
pcr
requir
less
time
labor
less
hour
reduc
handson
time
bibbi
et
al
kim
et
al
addit
close
pcr
system
reduc
chanc
amplicon
contamin
present
studi
limit
first
could
compar
larg
number
respiratori
virus
assay
due
low
number
virusposit
specimen
respiratori
viru
season
sinc
consecut
prospect
studi
perform
month
second
compar
viral
cultur
direct
fluorescentantibodi
assay
third
use
primer
monoplex
pcr
sequenc
discrep
analysi
howev
perform
monoplex
pcr
direct
sequenc
blind
manner
overcom
limit
studi
design
fourth
sinc
analyt
sensit
determin
use
plasmid
dna
revers
transcript
step
could
includ
estim
conclus
assay
produc
result
compar
assay
analysi
sampl
yield
discrep
result
demonstr
assay
exhibit
higher
concord
result
monoplex
pcr
sequenc
compar
assay
